Racepinephrine Inhalation Solution, USP 2.25%, Bronchodilator, For Oral Inhalation Only, Sulfite Free, Preservative Free, 30 x 0.5 mL Sterile Unit-of-Use Vials, each in a foil pouch, per carton, Nephron Pharmaceuticals Corporation, NDC 0487-5901-99.
Published August 17, 2022 · Recall initiated: June 29, 2022
Summary
FDA records drug Class II recall D-1325-2022, published August 17, 2022 and initiated June 29, 2022. Recalling firm: Mckesson Medical-Surgical Inc. Corporate Office; Status: Terminated; Reported quantity: 23 cartons. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations: products were stored outside the drug label specifications.
What to do
Voluntary: Firm initiated · Letter
Get an email if S2 has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- S2
- Manufacturer
- Mckesson Medical-Surgical Inc. Corporate Office
- Distributor
- Nationwide in the USA.
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAS2 Racepinephrine Inhalation Solution, USP 2.25% Bronchodilator 30x0.5 mL Sterile Unit-of-Use Vials each in aFebruary 1, 2023
- FDAAsthmanefrin Racephinephrine Inhalation Solution Bronchodilator, For temporary relief of mild symptoms ofAugust 17, 2022
- FDASterile Alcohol Prep Pads, Sterile, Latex Free, 100 large pads per box, manufactured for: Dynarex Corporation,August 17, 2022
- FDADakin's Solution, a) sodium hypochlorite 0.125%, quarter strength, NDC 0436-0672-16, b) sodium hypochloriteAugust 17, 2022
- FDAAlcohol Swabsticks, Antiseptic, 50 4" saturated individual packets per box, Manufactured for: DynarexAugust 17, 2022
- FDAA&D Original Ointment, Diaper Rash Ointment & Skin Protectant, 16 oz. Jar, Bayer Healthcare Pharmaceutica, NDCAugust 17, 2022
Questions about this recall
Was Racepinephrine Inhalation Solution, USP 2.25%, Bronchodilator, For Oral Inhalation Only, Sulfite Free, Preservative Free, 30 x 0.5 mL Sterile Unit-of-Use Vials, each in a foil pouch, per carton, Nephron Pharmaceuticals Corporation, NDC 0487-5901-99. recalled?
Yes. FDA published recall D-1325-2022 on August 17, 2022. Reported hazard: CGMP Deviations: products were stored outside the drug label specifications.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: S2.